Patents Assigned to Rythera Therapeutics, Inc.
  • Composition and method for prevention and treatment of anorectal disorders
    Patent number: 11173111
    Abstract: A composition comprising at least one TCA useful in a method for treating an anorectal disorder, a rectal device and method of treating the anorectal disorder by anorectally administering an effective amount of the TCA, e.g. amitriptyline.
    Type: Grant
    Filed: September 22, 2020
    Date of Patent: November 16, 2021
    Assignee: Rythera Therapeutics, Inc.
    Inventors: Reginald L. Hardy, Mitchell Brigell